Pharm Control Ltd. (fka PMCL)

[PhillyPA65]

THE MONKEY WRENCH

This PR is troubling. It appears to show collusion between whoever was releasing these PRs and the alleged selling of new shares by the transfer agent and accomplices. It is very likely that "Eugene Kron" is a fake name created by the people involved in selling the newly issued shares. Pharm Control Ltd does exist as evidenced by their web site and people who have ordered and received Control 24. Why would Pharm Control Ltd increase the authorized shares to 1 billion? That's the monkey wrench in the machine. It appears to be "Eugene Kron" giving himself, and the transfer agent, permission to dump 900 million more shares on the public. The thieves got greedy and OSC soon caught on in my opinion. Now, we wait and see if Dr. Lee can get over this hump and build a legitimate business.


Pharm Control Shareholder Update
Friday April 27, 9:30 am ET

NEW YORK, NY--(MARKET WIRE)--Apr 27, 2007 -- Pharm Control (Other OTC:PMCL.PK - News) would like to update its shareholders by advising that the Company anticipates the name change to Natural Medications Inc., the new CUSIP and new symbol to be processed by some time in early May 2007.

In addition, the Board of Directors increased the Authorized Shares to 1 billion in order to have the flexibility of possible financings in the future but also to pursue acquisitions, particularly manufacturing facilities in Southeast Asia.

As part of this potential growth, the Company is looking into listing the Company for trading in overseas markets with an emphasis on South East Asia.

About Pharm Control Ltd.

Pharm Control Ltd. is a leading medicine Research and Development company that is devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. The Company's founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in the modern world.

Safe Harbor Statement

The preceding includes forward-looking statements, which involve known and unknown risks, and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. Any forward-looking statements above are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including, without limitation, competition, intellectual property rights, litigation, needs of liquidity, and other risks detailed from time to time in the company's reports filed with the SEC. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the company's products and services, competition, new products and technological changes, as well as any and all "other risks" associated with business.

Contact:

Pharm Control Ltd.
Eugene Kron
Vice President
Email: [e-mail]
Tel: [phone]

Source: Pharm Control Ltd.